Clinical Trial Update: Tesetaxel for Previously Treated Patients With Bladder Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for Tesetaxel in previously treated bladder cancer (transitional cell carcinoma) patients; the trial status is currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Transitional Cell Carcinoma of the Bladder

Drugs mentioned

• tesetaxel (tesetaxel)

Snippet

Sponsor: Genta Incorporated | Conditions: Carcinoma, Transitional Cell | Phase 2 | Status: UNKNOWN